Review

SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications

Fig. 1. Systemic cardio-renal-metabolic reprogramming initiated by proximal tubular SGLT2 inhibition.
Open the figure at full size
Fig. 1. Systemic cardio-renal-metabolic reprogramming initiated by proximal tubular SGLT2 inhibition.Systemic cardio-renal-metabolic reprogramming initiated by proximal tubular SGLT2 inhibition.Zheng et al.

Molecular Biomedicine

The paper

First Affiliated Hospital of University of South China

Molecular Biomedicine · 30 Sep 2026

doi.org/10.1186/s43556-026-00604-3PubMed 42814168

More on SGLT2 inhibitors